You can teach an old dog new tricks: anti-malarial prevents cancer in mice

Dec 21, 2007

New data generated by a team of researchers from St Jude Children’s Research Hospital, Memphis, and Scripps Research Institute, Jupiter, have indicated that the antimalarial drug chloroquine effectively prevents cancer in mouse models of two distinct human cancer syndromes, Burkitt lymphoma and ataxia telangiectasia.

As discussed in the accompanying commentary by Chi Dang, from Johns Hopkins University School of Medicine, Baltimore, these results complement an old epidemiology study suggesting that malarial prophylaxis with chloroquine diminished the incidence of Burkitt lymphoma.

In the study, chloroquine was shown to inhibit the development of Myc-induced lymphomas (a mouse model of Burkitt lymphoma) and to inhibit the development of lymphomas in ATM-deficient mice (a mouse model of ataxia telangiectasia). By contrast, chloroquine did not inhibit the development of lymphomas in p53-deficient mice.

Further analysis indicated that chloroquine induced cellular features of autophagy (self-eating) and mediated its effects by inducing lysosomal stress and provoking a p53-dependent cell death. The authors therefore suggested that modulating autophagy, either using chloroquine or other approaches, might provide a new avenue for the development of anticancer therapeutics.

Source: Journal of Clinical Investigation

Explore further: Researchers find chemotherapy after bladder cancer surgery improved survival

add to favorites email to friend print save as pdf

Related Stories

Malaria transmission linked to mosquitoes' sexual biology

19 minutes ago

Sexual biology may be the key to uncovering why Anopheles mosquitoes are unique in their ability to transmit malaria to humans, according to researchers at Harvard T. H. Chan School of Public Health and University of Per ...

Fighting the Colorado potato beetle with RNA interference

19 minutes ago

Colorado potato beetles are a dreaded pest of potatoes all over the world. Since they do not have natural enemies in most potato producing regions, farmers try to control them with pesticides. However, this ...

Recommended for you

Deodorant use ok for radiotherapy patients

Feb 27, 2015

Women undergoing radiotherapy for breast cancer can use deodorant without fear of increased underarm skin reaction, pain, itching or burning, research suggests.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

HarryStottle
not rated yet Dec 22, 2007
Anyone qualified to comment on the potential connections between these findings and the more general chlorine-oxidation benefits reported by Thomas Hesselink MD?

http://bioredox.m...ilus.htm

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.